Holcim Discloses Controlling Stake Acquisition, Plans Tender Offer and NYSE Delisting
summarizeSummary
Holcim Ltd. has formally disclosed its acquisition of a 50.01% controlling stake in Cementos Pacasmayo SAA for S/1.85 billion, with plans for a subsequent public tender offer and eventual delisting from the NYSE.
check_boxKey Events
-
Controlling Stake Acquired
Holcim Ltd. completed the acquisition of a 50.01% controlling interest in Cementos Pacasmayo SAA on March 30, 2026, for an aggregate cash purchase price of S/1,850,370,000.
-
Mandatory Tender Offer Planned
Holcim is obligated to launch a public tender offer for at least an additional 24.99% of Cementos Pacasmayo's common shares within six months of the acquisition closing.
-
Intent to Delist from NYSE
Following the tender offer, Holcim intends to delist Cementos Pacasmayo's American Depositary Shares from the New York Stock Exchange and deregister them under the Exchange Act.
-
New Board Appointments
Holcim designated Santiago Maria Ojea Quintana and Simon Rolf Kronenberg as directors to Cementos Pacasmayo's Board of Directors on March 30, 2026.
auto_awesomeAnalysis
This Schedule 13D formally details Holcim Ltd.'s acquisition of a 50.01% controlling interest in Cementos Pacasmayo SAA, an event previously announced on March 31, 2026. The acquisition, valued at S/1.85 billion, establishes Holcim as the majority owner. The disclosure of a mandatory subsequent public tender offer for at least an additional 24.99% of shares, coupled with the intent to delist the company's American Depositary Shares from the NYSE and deregister under the Exchange Act, signals a significant shift in the company's ownership structure and public trading status. This move will likely reduce liquidity for public shareholders but could provide long-term stability under Holcim's strategic direction. Investors should monitor the progress of the tender offer and delisting process.
At the time of this filing, CPAC was trading at $10.52 on NYSE in the Manufacturing sector, with a market capitalization of approximately $945.3M. The 52-week trading range was $5.10 to $11.50. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.